Clinical trials
Recruiting Phase 3 Diabetes Mellitus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 1 |
| Consorcio Centro de Investigación Biomédica en Red (CIBER) | 1 |
| Energenesis Biomedical Co., Ltd. | 1 |
| Gan & Lee Pharmaceuticals. | 1 |
| JSC NextGen | 1 |
| Novo Nordisk A/S | 1 |
| Ole Lander Svendsen | 1 |
| Pfizer | 1 |
| The George Institute | 1 |
| University of Oklahoma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 10 |
| Diabetes Mellitus, Type 2 | 2 |
| Foot Ulcer | 2 |
| Obesity | 2 |
| Overweight | 2 |
| Atrial Fibrillation | 1 |
| Body Weight | 1 |
| Diabetic Foot | 1 |
| Endocrine System Diseases | 1 |
| Fibrosis | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.